FSI Stanford Publications

Compliance as an Explanatory Variable in Clinical Trials with Comments and Rejoinder

Journal Article

Authors
Bradley Efron - Stanford University
D. Feldman

Published by
J Amer Stat Assn, Vol. 86, page(s) 9-25
1991

Publications of interest

Effect of Beta-Blockade Mortality in Patients with Heart Failure: A Meta-Analysis of Randomized Clinical Trials
Paul A. Heidenreich, T.T. Lee, B. Massie
Journal of the American College of Cardiology vol. 30 (1997)
Role of Economic Models in Randomized Clinical Trials
Mark A. Hlatky
American Heart Journal vol. 137 (1999)
Modeling Cost-Effectiveness of Helicobacter pylori Screening to Prevent Gastric Cancer: A Mandate for Clinical Trials
Julie Parsonnet, Douglas K. Owens, H.H. Hack, Douglas K. Owens
Lancet vol. 348 (1996)
Randomized Trials of Coronary Artery Bypass Surgery: Impact on Clinical Practice at Duke University Medical Center
RM Califf, Mark A. Hlatky, DB Mark, KL Lee, FE Harrell Jr, RA Rosati, DB Pryor
Circulation vol. 72, Suppl V (1985)